Characterization of cefotaxime- and ciprofloxacin-resistant commensal Escherichia coli originating from Belgian farm animals indicates high antibiotic resistance transfer rates by Lambrecht, Ellen et al.
MECHANISMS
Characterization of Cefotaxime- and Ciprofloxacin-
Resistant Commensal Escherichia coli Originating
from Belgian Farm Animals Indicates
High Antibiotic Resistance Transfer Rates
Ellen Lambrecht,1,2,* Eva Van Meervenne,1,2,* Nico Boon,2 Tom Van de Wiele,2
Pierre Wattiau,3 Lieve Herman,1 Marc Heyndrickx,1,4 and Els Van Coillie1
Food-producing animals represent one of the sources of antibiotic resistant commensal bacteria. There is an
increasing awareness that these bacteria might have the potential to transfer their resistance genes to other
(pathogenic) bacteria. In this study, 50 commensal Escherichia coli strains originating from food-producing
animals and resistant to the ‘‘highest priority, critically important antibiotics’’ cefotaxime and/or ciprofloxacin,
were selected for further characterization. For each strain (i) an antibiogram, (ii) the phylogenetic group, (iii)
plasmid replicon type, (iv) presence and identification of integrons, and (v) antibiotic resistance transfer ratios
were determined. Forty-five of these strains were resistant to 5 or more antibiotics, and 6 strains were resistant
to 10 or more antibiotics. Resistance was most common to ampicillin (100%), sulfamethoxazole, ciprofloxacin
(82%), trimethoprim, tetracycline (74%), cefotaxime, (70%) and ceftazidime (62%). Phylogenetic groups A
(62%) and B1 (26%) were most common, followed by C (8%) and E (4%). In 43 strains, more than 1 replicon
type was detected, with FII (88%), FIB (70%), and I1 (48%) being the most encountered types. Forty strains,
positive for integrons, all harbored a class I integron and seven of them contained an additional class II integron.
No class III integrons were detected. The antibiotic resistance transfer was assessed by liquid mating experi-
ments. The transfer ratio, expressed as the number of transconjugants per recipient, was between 10-5 and 100
for cefotaxime resistance and between 10-7 and 10-1 for ciprofloxacin resistance. The results of the current
study prove that commensal E. coli in food-production animals can be a source of multiple resistance genes and
that these bacteria can easily spread their ciprofloxacin and cefotaxime resistance.
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Introduction
Less than 100 years after the discovery of the firstantibiotic, bacterial resistance to antimicrobial sub-
stances is considered a global public health threat. While
antibiotic resistance develops naturally over time, misuse
and overuse of antibiotics accelerate and increase this pro-
cess, threatening treatment of infections.1 Although it is
difficult to exactly quantify the impact of antibiotic resis-
tance, the burden associated with antibiotic resistance in
selected multidrug resistant bacteria in the European Union
(EU), in terms of number of infections and deaths, has been
estimated at *400,000 infections and 25,000 attributable
deaths annually.1,2
Food-producing animals represent one of the sources of
antibiotic resistant bacteria, but it remains challenging to
determine their risk to human health due to the complexity
of transmission routes between farms and consumers and the
frequent transfer of resistance genes among host bacteria.3,4
Both pathogenic bacteria and commensal bacteria can
harbor and transfer antimicrobial resistance genes. While
the ingestion of antibiotic resistant pathogenic bacteria may
represent a direct hazard to public health, the transmission
of antibiotic resistance genes from commensal bacteria may
represent an indirect hazard, increasing the gene pool from
which (pathogenic) bacteria can acquire resistance genes.5
Since the first observation of multiresistant bacteria in the
1950s,6 it has become clear that antibiotic (multi)resistance
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is actually an ancient natural phenomenon, exhibited by the
presence of (transferable) resistance genes in metagenomes
of ancient isolated caves and permafrost sediments.7–10
Emergence of multiresistance and transfer of antimicrobial
resistance genes are associated with genetic elements such
as plasmids, transposons, and integrons. Plasmids inherently
are able to exist extra-chromosomally, replicate autono-
mously, and have the ability to be horizontally transferred
between distinct hosts.11 Many known antibiotic resistance
genes are located on plasmids.12 Historically, plasmids have
been classified in incompatibility (Inc) groups on the basis
of mutual incompatibility, that is, two plasmids of the same
group, share common replication and partitioning elements,
and are unable to stably coexist in the same cell.13 Plasmids
have been shown to be very efficient tools in the acquisi-
tion and dissemination of antimicrobial resistance between
members of the Enterobacteriaceae family.14 Many resis-
tance plasmids carry additional genetic elements such as
transposable elements and integrons.
In 1989, integrons were identified as key players in the
dissemination of resistance genes among Gram-negative
bacterial pathogens, mainly by their location on transpos-
able elements and conjugative plasmids.15 Integrons are
immobile elements that can easily capture, integrate, express,
and release gene cassettes encoding antibiotic resistance
genes.16 Based on the sequence of the encoded integrases,
five different integron classes can be distinguished among
the mobile integrons, of which only the first three are histor-
ically associated with the dissemination of multiresistance.16
On January 1, 2014, the harmonized monitoring and re-
porting of antimicrobial resistance became mandatory in the
EU for the pathogens Salmonella spp. and Campylobacter
jejuni and was recommended for Campylobacter coli, in-
dicator commensal Escherichia coli, Enterococcus faecalis,
and Enterococcus faecium. In 2011, the Federal Agency for
the Safety of the Food Chain (FASFC) in Belgium started
with the monitoring of antimicrobial resistance in indicator
bacteria in fecal samples of food-producing animals.17 Since
commensal E. coli have to survive in the lower intestinal
tract, they have to gain resistance by acquisition of resis-
tance genes or the development of mutations when chal-
lenged by antimicrobial pressures imposed on their host.
Hence, commensal E. coli are generally regarded as good
indicators for resistance among Gram-negative bacteria.14 In
addition, monitoring the commensal antibiotic reservoir is
important as it has been suggested that commensal antibiotic
resistance can be a greater global health threat than the di-
rect selection pressure on the pathogenic bacteria. More
specifically because the occasional de novo development
of resistance due to mutations in a pathogen may be less
frequent and less impactful than the constant gene traffic
from the vast commensal reservoir into the relatively small
pathogen pool.18
To manage the use of antibiotics and cope with the
worldwide problem of emerging multiresistance, the WHO
ranked antibiotics according to their importance in human
medicine.19 Among the highest priority, critically important
antibiotics on the list are ciprofloxacin (second generation
fluoroquinolone) and cefotaxime (third generation cepha-
losporins). Several studies indicate that the prevalence of
cefotaxime and/or ciprofloxacin resistant bacteria in food-
producing animals has reached worryingly high values.20–24
In this study, a collection of commensal E. coli strains
originating from food-producing animals was selected based
on the presence of resistance to cefotaxime or ciprofloxacin.
The goal of this study was to further characterize these se-
lected strains by (i) determining the antibiogram, and as-
sessing the (ii) phylogenetic group, (iii) plasmid replicon
type, (iv) presence and identity of integrons, and (v) anti-
biotic resistance transfer ratio.
Materials and Methods
Bacterial strains
A total of 845 E. coli isolates were analyzed for antibi-
otic susceptibility (EUMSV2 plate Trek Diagnostics, West
Sussex, United Kingdom) by the Belgian national reference
laboratory, Veterinary and Agrochemical Research Centre
(CODA-CERVA) within the nationwide antimicrobial re-
sistance surveillance program of commensal indicator bac-
teria of the Belgian Federal Agency for Safety of the Food
Chain (AFSCA-FAVV) for 2013. These strains originated
from cecal content of broiler chickens (n = 234) and fecal
material of pigs (n= 205), cattle (n= 204), and veal (n= 202).
Samples were taken under the authority of the Belgian Food
Agency at the slaughterhouse or at the farm. Eighty-five
strains resistant to cefotaxime and/or to ciprofloxacin were
selected. For the ciprofloxacin resistant strains, only the
strains which were resistant to ciprofloxacin and not to na-
lidixic acid were selected, as this reduces the chance that the
resistance is caused by a chromosomal mutation. From this
selection, 50 strains, showing pure culture on agar plates,
mainly originating from broiler chickens, were further an-
alyzed in this study (i.e., 15 ciprofloxacin resistant and 34
cefotaxime resistant strains and 1 strain resistant to both
antibiotics).
Antimicrobial susceptibility profiles
In 2014, harmonized monitoring became mandatory for in-
dicator commensal E. coli at EU level and the panel of antimi-
crobial substances for the antimicrobial susceptibility testing
changed.25 Therefore, the antibiotic susceptibility profiles of the
50 selected strains were determined again with the new panel of
14 antibiotics using the microbroth dilution method EUVSEC
Sensititre (Thermo Fisher, West Sussex, United Kingdom).
Using an overnight Tryptic Soy Broth culture, a bacterial sus-
pension with an optical density of 0.5 McFarland was prepared
by suspending one to three colonies in sterile distilled water. Ten
microliters of this suspension were added to 11 ml cation ad-
justed Mueller Hinton broth with N-tris(hydroxymethyl)methyl-
2-aminoethanesulfonic acid (TES) buffer (Thermo Fisher). Fifty
microliters of this inoculated broth were transferred to an
EUVSEC plate, which contains dilutions of 14 lyophilized an-
tibiotics according to the European directives.25 The plates
were incubated for 24 hr at 35C before being analyzed with
the Sensititre Vizion system (Thermo Fisher). The mini-
mum inhibitory concentration (MIC) is defined as the lowest
concentration at which no visible growth can be detected. A
strain is considered resistant to an antimicrobial substance
if the MIC value is higher than the EUCAST epidemio-
logical cutoff values (ECOFF values, https://mic.eucast
.org/Eucast2).
2 LAMBRECHT ET AL.
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Phylogenetic groups
The phylogenetic group of the strains was determined
using the protocol of the quadruplex phylogroup assignment
method of Clermont et al. with some minor modifications.26
PCRs were carried out in a total volume of 50 ml containing
1· buffer II (Thermo Fisher) 1.5 mM MgCl2, 40 mM dNTPs,
2 U of AmpliTaq DNA polymerase (Thermo Fisher), 30–
80 ng DNA, and the appropriate primers. The amounts of
primers used in the quadruplex PCR were 20 pmol, except
for AceK.f (100 pmol) and ArpA1.r (100 pmol). In the
allele-specific phylogroup E PCR the amounts of primers
were 20 pmol for ArpAgpE.f and ArpAgpE.r and 12 pmol
for trpBA.f and trpBA.r. In the allele-specific phylogroup C
PCR the amounts of the primers trpAgpC.1 and trpAgpC.2
were 20 pmol, while the primers providing the internal
control were adjusted: AceK.f (100 pmol) and ArpA1.r
(100 pmol). PCRs were performed under the following
conditions for the quadruplex PCR: denaturation 5 min at
94C, 35 cycles of 30 sec at 94C, 30 sec at 55C, and 30 sec
at 72C, and a final extension step of 7 min at 72C. For the
allele-specific phylogroup E PCR the annealing temperature
was 57C and for the allele-specific phylogroup C PCR
it was 59C. The PCR amplification products were sepa-
rated by electrophoresis on a 1% SeaKem LE agarose gel
(Cambrex Bio Science, Wiesbaden, Germany) in 0.5 ·TAE
buffer (Thermo Fisher), visualized by ethidium bromide
staining and photographed under ultraviolet (UV) light.
Plasmid replicon typing
To determine which plasmid replicons were present in the
strains, five triplex PCRs and five simplex PCRs were op-
timized based on the PCR-based replicon typing method
of Carattoli et al.27 PCRs were carried out in a total volume
of 50 ml containing 1· buffer II, 1.25 mM MgCl2, 50mM
dNTPs, 1.5 U of AmpliTaq DNA polymerase, 30–80 ng
DNA. In the triplex PCRs 1 mM of each primer was added,
except in the X–L/M–N PCR, in which 2mM of the X primers
were added. For the simplex PCRs, the same composition
was used with 1 mM of each primer. The PCR program was
as follows: denaturation for 5 min at 94C, followed by 30
cycles of 1 min at 94C, 30 sec at the appropriate annealing
temperature and 1 min at 72C, and a final extension step of
5 min at 72C. The annealing temperature of the 10 PCRs
was as follows: 54C for FII, 60C for A/C–T–FIIS, FIA–
FIB–W, X–L/M–N, B/O, K, R, and U, 64C for Y–P–FIC,
and 65C for HI1–HI2–I. The PCR amplification products
were separated by electrophoresis on a 1% SeaKem LE
agarose gel in 0.5 ·TAE buffer, visualized by ethidium
bromide staining, and photographed under UV light.
Presence of integrons
The presence of integrons was detected with PCR us-
ing degenerate primers hep35 and hep36, targeting the
conserved regions of integrase genes intI1, intI2, and intI3.28
The PCR mix contained 1 · buffer II, 0.75 mM MgCl2, 1.5 U
AmpliTaq DNA polymerase, 50 mM dNTPs, 1 mM of each
primer, and 2 ml DNA extract (25 ng/ml) in a total volume of
50 ml. The reaction parameters were 2 min denaturation at
94C followed by 30 cycles at 94C for 2 min, 55C for
1 min, and 72C for 1 min, and a final extension at 72C for
10 min as described by Nagachinta and Chen.29 The PCR
amplification products were separated by electrophoresis on
a 1% SeaKem LE agarose gel in 0.5 ·TAE buffer, visual-
ized by ethidium bromide staining and photographed under
UV light.
Determination of integron class
Integron-positive samples were further analyzed to iden-
tify the integron class (class I, class II, or class III) by re-
striction fragment length polymorphism as described by
White et al.30 Briefly, PCR products amplified with hep35/
hep36 primers from the conserved regions of the integrase
genes were digested (37C, 3 hr) with HinfI (New England
Biolabs, Ipswich, MA). Digestion products were separated
by electrophoresis (100 V) on a 2% SeaKem LE agarose gel
in 0.5 ·TAE buffer, visualized by ethidium bromide stain-
ing and photographed under UV light.
Afterward, the assigned integron classes were confirmed
by PCR with class-specific primers, IntI1-F and IntI1-R for
integron class I and IntI2-F and IntI2-R for integron class
II.31 The composition of the PCR mix was similar as the one
described above. The PCR parameters for integron class I
were 3 min denaturation at 94C, followed by 35 cycles of
1 min at 94C, 30 sec at 68C, 1 min at 72C, and a final
extension for 7 min at 72C. The ones for integron class II
were 5 min denaturation at 94C, followed by 30 cycles of
30 sec at 94C, 30 sec at 62C, 1 min at 72C, and a final
extension for 8 min at 72C. The PCR amplification prod-
ucts were separated and visualized as described above.
Antibiotic resistance transfer
The transfer of cefotaxime (FOT) and ciprofloxacin (CIP)
resistance was analyzed by liquid mating. The recipient
strain was E. coli K12 MG1655, which was first made ri-
fampicin (RIF) resistant by serial inoculation on Tryptic Soy
Agar plates with increasing concentrations of rifampicin
(4–128 mg/L). Donor (50 strains, FOTR and/or CIPR) and
recipient (E. coli K12 RIFR) strains were each inoculated
on Luria Bertani (LB) plates without any antibiotics and
incubated overnight at 37C. The next day 1 colony of each
strain was transferred to 5 ml LB broth containing the se-
lective antibiotic (50 mg/L rifampicin for the recipient
strain, 0.25 mg/L cefotaxime or 0.064 mg/L ciprofloxacin
for the donor strains) and incubated by shaking (150 rpm) at
37C. After 16 hr the strains were washed thrice with LB.
Subsequently the strains were 10-fold diluted in LB, and
liquid mating was performed by adding 300 ml of a donor
strain to 1,500ml of the recipient strain in a glass test tube.
All tubes were incubated by shaking (150 rpm) at 37C for
23 hr. After incubation, cultures were diluted and plated on
selective LB plates. For the mating experiments with cefo-
taxime resistant donor strains this was LB with rifampicin
(50 mg/L) and cefotaxime (0.25 mg/L) for quantification of
the transconjugants, LB with rifampicin for the recipients,
and LB with cefotaxime for the donors. For the cipro-
floxacin resistant donor strains this was LB with rifampicin
(50 mg/L) and ciprofloxacin (0.064 mg/L) for the transcon-
jugants, LB with rifampicin for the recipients, and LB with
ciprofloxacin for the donors. After overnight incubation at
37C, the colonies on the plates were counted. The detection
limit was 10 CFU/ml (1 colony/100 ml), and the limit of
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quantification was set at 1.5 · 102 CFU/ml (‡15 colonies/
plate were regarded as reliable for quantification). The transfer
ratio was calculated by dividing the number of transconju-
gants by the number of recipients.
The reproducibility of the liquid mating technique was
assessed by performing triplicate setups of six selected do-
nor strains. Negative controls (donor strain MB 5876 with-
out added recipient strain and vice versa) were included.
Statistical analysis
To elucidate associations between sets of two nominal
variables (origin, phylogenetic group, integron class, and
plasmid replicon type) a two-tailed Fisher’s exact test with
Bonferroni correction for multiple testing was performed. p-
Values lower than 0.003 (after Bonferroni correction) were
considered as significant.
Quantitative data were examined for normality by the
Shapiro–Wilk test and Q-Q plots. Both ciprofloxacin and
cefotaxime transfer ratios and the number of observed an-
tibiotic resistances were not normally distributed. A non-
parametric Kruskal–Wallis test by ranks with Bonferroni
correction was conducted to reveal if the transfer ratios were
different among phylogenetic groups, strain origins, inte-
gron classes, and plasmid replicon types. p-Values lower
than 0.003 (after Bonferroni correction) were considered as
significant.
The calculations were performed using the statistical soft-
ware R version 3.3.3 (R Foundation for Statistical Com-
puting, Vienna, Austria).
Results
Antimicrobial susceptibility profiles
The antimicrobial susceptibility profiles of the 50 selected
E. coli strains were determined using the antibiotic panel
(Table 1). Forty-five strains were resistant to five or more
antibiotics. Among the most commonly observed resistances
were ampicillin (100%), sulfamethoxazole, ciprofloxacin
(both 82%), trimethoprim, tetracycline (both 74%), cefotax-
ime (70%), and ceftazidime (62%). Two strains (MB5900
and MB5917) isolated from broiler chickens were only re-
sistant to two antibiotics, more specifically ciprofloxacin
and ampicillin. In contrast, there were 2 strains (MB5903
and MB5916) originating from veal, which were resistant
to 11 antibiotics (sulfamethoxazole, trimethoprim, cipro-
floxacin, tetracycline, azithromycin, cefotaxime, nalidixic
acid, chloramphenicol, ceftazidime, ampicillin, and genta-
micin). All tested strains were susceptible to meropenem
and tigecycline. There was only 1 strain in the collection
(MB5918, originating from broiler and resistant to 10 an-
tibiotics), which was resistant to colistin.
Phylogenetic groups
The phylogenetic group was determined using a quad-
ruplex and two duplex PCR (Table 1). Table 2 presents the
distribution of the phylogenetic groups per animal species.
Phylogenetic group A and B1 were the most common
phylogenetic groups among the analyzed strains. In each
animal species only one strain belonged to phylogenetic
group C.
Plasmid replicon typing
The presence of 20 plasmid replicons was investigated by
means of 5 triplex PCRs and 5 simplex PCRs. Replicons of
following plasmid incompatibility groups were not detected
among the analyzed strains: A/C, FIIAS, HI2, L/M, T, W,
and X. In 43 strains, more than one replicon was detected.
In strain MB5933 six replicons were detected. The most
common replicons were FII, FIB, and I1 (Fig. 1).
Integrons
Forty out of the 50 tested strains were positive for in-
tegrons (Table 1). All positive strains harbored a class I
integron and seven of them contained an additional class II
integron. No class III integrons were detected.
Antibiotic resistance transfer
The transferability of cefotaxime or ciprofloxacin resis-
tances was determined by the reproducible liquid mating
method (Fig. 2 and Table 1). In each mating 108 CFU of
the recipient strain was added to 2.8 · 106–7.8 · 107 CFU of
each cefotaxime resistant donor strain and 1.6–5.4 · 107
CFU of each ciprofloxacin resistant donor strain. There were
five cefotaxime resistant strains that failed to grow on the
selective LB plates. Hence, after mating, neither donors
nor transconjugants were detected for these strains. For
nine other strains, the number of transconjugants was below
the limit of quantification. For the remaining 21 strains, the
cefotaxime resistance transfer ratio, that is, the ratio of the
number of transconjugants to the number of recipients, was
in the order of magnitude of 10-5–100. A transfer ratio of
100 means that all recipients have gained the plasmid. Re-
garding the ciprofloxacin resistant strains, there were two
strains for which the number of transconjugants was below
the detection limit. For the other 14 strains, the transfer ratio
was in the range of 10-7–10-1.
In the control setup in which the recipient (RIFR) was
incubated without a donor strain, no cefotaxime resistant
bacteria were detected. However, incubation of a donor
strain (FotR) without recipient resulted in some rifampicin
resistant bacteria (<1.5 · 102 CFU/ml), caused by sponta-
neous mutations (3.2 · 10-9 mutated donors/total number of
donors).
Transfer ratios could not be linked to strain origin, phy-
logenetic group, integron classes, and plasmid replicon
types (Kruskal–Wallis tests, p > 0.003 after Bonferroni cor-
rection).
Moreover, no significant associations could be found be-
tween strain origin, phylogenetic group, integron class, and
plasmid replicon type (Fisher’s exact test, p > 0.003).
Discussion
Antibiotics are widely used in food-producing animals for
therapeutic treatment of clinically sick animals, for disease
prophylaxis during periods of high risk of infection and for
growth promotion. Several studies have demonstrated as-
sociations between antibiotic use in food-producing animals
and the prevalence of antibiotic-resistant bacteria and re-
sistance genes in those animals.3,32–37 As antibiotic use is
regarded as an important driver of resistance selection and
spread, its use as a growth promoter is forbidden in Europe
4 LAMBRECHT ET AL.
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since 2006.38 Antibiotic resistant bacteria from food-producing
animals can spread to humans through, for example, the
food supply or direct contact with animals and through
several indirect routes, for example, the use of contaminated
manure as soil fertilizer.39,40 The current study character-
ized cefotaxime and/or ciprofloxacin resistant, commensal
E. coli, previously isolated from food-producing animals
and determined their resistance transfer potential.
Besides their cefotaxime and/or ciprofloxacin resistance,
the majority of the strains were resistant to several other
antibiotics, and six strains were even highly multiresistant,
exhibiting resistance to 10 up to 11 antibiotics. The domi-
nant resistances detected in the current study were those
toward ampicillin, sulfamethoxazole, trimethoprim, and
tetracycline. Penicillins, sulfonamides, and tetracyclines are
among the most commonly used antibiotic compounds in
food-production animals in Belgium.41 Chantziaras dem-
onstrated that the use of these antimicrobials strongly cor-
relates with the level of resistance toward these agents found
in commensal E. coli isolates in pigs, poultry, and cattle in
Belgium.32
Although these commensal strains are generally regarded
as nonpathogenic for humans, presence of antibiotic resis-
tance genes in these strains is very relevant as they might
transfer their resistance genes to other (pathogenic) bacteria.
The results of the liquid mating assay demonstrated that
ciprofloxacin and cefotaxime resistance could be easily
transferred; however, considerable variation in transfer ratio
was observed between the tested strains (CIPR transfer ratio:
10-7–10-1 and FOTR transfer ratio: 10-5–100). This varia-
tion could not be explained by strain origin, phylogenetic
group, integron class, or replicon type, but might be caused
by the genetic background of the donor or plasmid related
factors affecting transfer, for example, by interfering with
the cell contact. Strain (and species) variation in transfer
ratios despite identical mating conditions has also been
observed by others.42–44
Its important to note that in the current study, the 2 strains
with the highest number (11) of observed antibiotic resis-
tances had some of the highest transfer ratios. However, no
significant correlation between the number of antibiotic re-
sistance genes and transfer ratios could be detected.
As there is extensive genetic substructure within the
species E. coli, they can be assigned to phylogenetic groups.
There is increasing evidence that strains of various phylo-
genetic groups differ in phenotypic and genotypic charac-
teristics.26 In general, B1, B2, A, and D are regarded as the
most prevalent phylogroups.45 In the current study the tested
commensal E. coli mainly belonged to group A and B1. No
members of group B2 and D were detected. While some
authors claim that commensal strains predominantly belong
to group A and B1,26,46 which is consistent with our results,
this could not be confirmed by others.47 These discrepant
observations could be due to matrix (human vs. animal) and
population differences and to different phylotyping meth-
ods. Apart from the phylogroup, the replicon types were
determined for each strain. The replicon type of the plasmid
determines if the plasmid can stably coexist with other
plasmids in the recipient cell. Type FII and FIB were most
prevalent, followed by I1. The first two replicon types are
indicators of the presence of IncF plasmids. These plasmids
are often detected in the Enterobacteriaceae and represent
one of the most frequently reported plasmid types. F plas-
mids can contain multiple F replicons and, like I1 plasmids,
have been described as narrow host range plasmids.48,49
Both IncF and IncI1 have been shown to be associated
with the spread of antibiotic resistance genes, including
extended-spectrum b-lactamase, quinolone, and aminogly-
coside resistance genes.10,49 IncF plasmids express long
flexible pili and are efficiently transferred in liquid cultures,
Table 2. Distribution of the Phylogenetic Groups
Origin A B1 C E Total
Veal 4 2 1 — 7
Broiler 24 8 1 2 35
Cattle 1 3 1 — 5
Pig 2 - 1 — 3
Total (%) 31 (62) 13 (26) 4 (8) 2 (4) 50 (100)
FIG. 1. Distribution of the plasmid replicons determined by PCR-based replicon typing.
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whereas IncI plasmids express short rigid pili and are known
to transfer more efficiently among cells on a surface.50 The
liquid matings performed in the current study did not allow
to verify the enhanced transfer of IncF plasmids in liquid
cultures as many strains harbored multiple plasmids and it
was not determined which particular plasmid(s) was/were
transferred.
Eighty percent of the E. coli strains contained integrons,
which is high compared to other studies (e.g., 40%,31
7.5%,44 60%,51 and 60.1%52). This might be explained by
differences in characteristics of the analyzed strain collec-
tion as in several studies; also antibiotic susceptible strains
and/or pathogenic strains were taken into account. Our study
exclusively tested cefotaxime/ciprofloxacin resistant com-
mensal strains, mainly from broiler (70%) origin. The se-
lection of cefotaxime/ciprofloxacin resistant strains may
have favored the presence of integrons. This statement is
supported by other studies which reported a high (66–97%)
prevalence of integrons in multiresistant (incl. cefotaxime/
ciprofloxacin) E. coli strains.23,53–55
In the current study, class I was the most abundant in-
tegron group, and no class III integrons were detected. This
is in line with multiple other studies which demonstrate that
class I integrons are most frequently encountered, followed
by class II integrons and the rarely detected class III in-
tegrons.31,52,56 As integrons are known to be involved in the
emergence of multiple antibiotic resistance it is not sur-
prising that the 2 strains with the lowest amount (2) of
observed antibiotic resistances did not have detectable in-
tegrons, and the 6 highly multiresistant strains (10 and 11
resistances) all carried class I integrons.
The results of the current study prove that commensal E.
coli in food-producing animals can be a source of multi-
resistant bacteria and that some bacteria can easily spread
their ciprofloxacin and cefotaxime resistance genes to re-
cipients under certain tested in vitro conditions. Further
research is needed to annotate the plasmids, to determine the
location of antibiotic resistance genes and integrons, and to
identify factors that enable plasmid maintenance and sta-
bility in the recipient. Moreover, the high antibiotic resis-
tance transfer ratios observed in vitro in certain strains
should be validated in human gastrointestinal environments
to meet the need of quantitative data under circumstances
more closely related to the actual situation of food con-
sumption.
Lazarus et al.57 concluded that there is evidence that a
proportion of human extraintestinal infections caused by
expanded-spectrum cephalosporin-resistant E. coli origina-
tes from food-producing animals, with poultry as the more
likely source. They also denoted that there is a lack of
knowledge regarding the specific parameters, such as the
magnitude and geographical extent of the problem sur-
rounding the transmission of bacteria and genetic elements
from poultry to humans. In the current study, the majority of
the cefotaxime and/or ciprofloxacin resistant strains were
from broiler origin. As the number of tested strains per
animal species was similar, this confirms that broiler
chickens are an important source of resistant bacteria. It has
been estimated that the probability to be exposed to more
than 1,000 CFU of cephalosporin resistant E. coli by a
prepared serving with broiler meat is about 1.5%.58 The
implications for human health are unknown, because the
FIG. 2. Reproducibility of the liquid mating method. Liquid mating was performed in LB at 37C for 23 hr with various
Escherichia coli donor strains and one acceptor strain (E. coli K12 RIFR). Mean – standard deviation, n = 3. LB, Luria
Bertani.
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minimal infectious dose and the factors influencing the
transfer of antimicrobial resistance genes from E. coli to the
human intestinal bacterial community are not understood
well enough.
The high number of antibiotic resistances and high
transfer ratios demonstrated in commensal E. coli originat-
ing from Belgian farm animals in 2013 underscore that
commensal E. coli in food production animals can be a
reservoir and vector for antibiotic resistances.
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